Enrasentan | Interleukin Related interleukin-related.com

Product Name :
Enrasentan

Search keywords :
Enrasentan

drugId :
null

Target Vo:
Endothelin receptor type A

Target Vo Short Name :
ETAR

Moa_Name:
Endothelin receptor type B antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Glaxosmithkline Plc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Pulmonary Arterial Hypertension

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-CDK1 (Tyr15) Antibody
Glucose Transporter GLUT4 Antibody (YA753)
HMGB1 Antibody: HMGB1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to HMGB1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts